Category: News

http://www.oecd.org/daf/competition/workshop-on-recent-challenges-in-competition-and-ip-in-pharmaceutical-markets.htm

Antitrust and Silicon Valley: New Themes and Direction in Competition Law and Policy

The antitrust analysis of product hopping is nuanced. The conduct, which consists of a drug company’s reformulation of its product and encouragement of doctors to switch prescriptions to the reformulated product, sits at the intersection of antitrust law, patent law, the Hatch-Waxman Act, and state substitution laws, and involves uniquely complicated markets with different buyers … Continue reading Prof. Carrier writes article on product hopping…

Professor Carrier was quoted in the N.Y. Times on Allergan’s strategy of transferring patents to a Native American tribe to avoid review at the Patent Office.